Načítá se...
Immune checkpoint inhibition in the treatment of early stage triple negative breast cancer: 2021 update
There is an emerging body of evidence regarding the use of immunotherapy in early-stage triple negative breast cancer (TNBC), with the recent publication of several phase III and randomised phase II studies examining the role of immune checkpoint inhibitors (ICI) in the neoadjuvant setting in combin...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2022-03-01
|
| Edice: | Breast |
| Témata: | |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S0960977621010250 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|